We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$119M
2
STI
SunTrust Banks, Inc.
STI
+$55.9M
3
AAPL icon
Apple
AAPL
+$48.3M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$22M
5
VIAB
Viacom Inc. Class B
VIAB
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDEX
2926
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$32K ﹤0.01%
303
-3
-1% -$400
ECOR icon
2927
electroCore
ECOR
$60.4M
$31K ﹤0.01%
1,305
+36
+3% +$917
JILL icon
2928
J. Jill
JILL
$280M
$31K ﹤0.01%
5,472
+60
+1% +$471
UMC icon
2929
United Microelectronic
UMC
$48.2B
$31K ﹤0.01%
11,474
– –
USWS
2930
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$30K ﹤0.01%
762
+24
+3% +$874
ACET icon
2931
Adicet Bio
ACET
$74.1M
$29K ﹤0.01%
176
+2
+1% +$1.01K
CKPT
2932
DELISTED
Checkpoint Therapeutics
CKPT
$29K ﹤0.01%
1,701
– –
ASXC
2933
DELISTED
Asensus Surgical, Inc.
ASXC
$29K ﹤0.01%
19,414
+112
+0.6% +$389
CTRC
2934
DELISTED
Centric Brands Inc. Common Stock
CTRC
$27K ﹤0.01%
12,311
+400
+3% +$1K
NTGN
2935
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$26K ﹤0.01%
21,720
– –
PHUN icon
2936
Phunware
PHUN
$44.6M
$24K ﹤0.01%
404
+127
+46% +$8.75K
XELA
2937
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$24K ﹤0.01%
5
– –
YCBD icon
2938
cbdMD
YCBD
$5.94M
$23K ﹤0.01%
+28
New +$33.6K
ASAP
2939
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$20K ﹤0.01%
3,120
-45
-1% -$498
GSAT icon
2940
Globalstar
GSAT
$10.7B
$16K ﹤0.01%
2,060
– –
FBRX icon
2941
Forte Biosciences
FBRX
$1.57B
$14K ﹤0.01%
71
-1
-1% -$227
FLEX icon
2942
Flex
FLEX
$45.3B
– –
-116,045
Closed -$915K
GIFI
2943
DELISTED
Gulf Island Fabrication
GIFI
– –
-23,519
Closed -$126K
IWV icon
2944
iShares Russell 3000 ETF
IWV
$20.2B
– –
-11,607
Closed -$2.02M
TTSH
2945
DELISTED
Tile Shop Holdings
TTSH
– –
-123,872
Closed -$395K
VTI icon
2946
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
– –
-6,903
Closed -$1.04M
PHAS
2947
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-10,182
Closed -$42K
ENFC
2948
DELISTED
Entegra Financial Corp.
ENFC
– –
-10,569
Closed -$317K
GWR
2949
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-141,895
Closed -$15.7M
LKSD
2950
DELISTED
LSC Communications, Inc.
LKSD
– –
-52,201
Closed -$72K
116 117
118
119 120

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.